Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science (LIMS), La Trobe University, Melbourne, Australia.
Department of Applied Biological Science, Graduate School of Agriculture, and Global Innovation Research Organisation, Tokyo University of Agriculture and Technology, Tokyo Japan.
PLoS One. 2019 Jan 4;14(1):e0210003. doi: 10.1371/journal.pone.0210003. eCollection 2019.
Extracellular vesicle (EV) microRNAs are of major interest as potential diagnostic biomarkers in all cancer types. This study aims to identify miRNA profiles of shed microvesicles (sMVs) and exosomes (Exos) secreted from the isogenic colorectal cancer (CRC) cell lines SW480 and SW620 and evaluate their ability to predict CRC. Deep sequencing of miRNAs in parental cell lysates (CLs) and highly-purified sMVs and Exos was performed. We focused on miRNAs enriched in EVs and dysregulated miRNAs in metastatic cells (SW620) relative to primary cancer cells (SW480). We investigated the ability of EV miRNA signatures to predict CRC tumours using 594 tumours (representing different pathological stages) and 11 normal samples obtained from TCGA. In SW480 and SW620 cells we identified 345 miRNAs, of which 61 and 73 were upregulated and downregulated in SW620-CLs compared to SW480-CLs, respectively. Selective distribution of cellular miRNAs into EVs results in distinct miRNA signatures for sMVs and Exos in each cell line. Cross cell line comparisons of EV miRNA profiles reveal a subset of miRNAs critical in CRC progression from primary carcinoma to metastasis. Many miRNAs non-detectable (<5 TPM) in CLs were significantly enriched (>1000 TPM) in secreted EVs. Strikingly, miR-7641 which is non-detectable in SW480-CL but upregulated in SW620-CL is highly enriched in EVs secreted from both cell lines. Pearson correlation analysis demonstrated that EV miRNA profiles can be used to predict CRC tumours with ~96% accuracy. Our findings suggest that EV miRNA profiles from CRC cell lines may allow prediction of CRC tumours, and that miR-7641 may serve as an attractive candidate for the specific, non-invasive diagnosis and prognosis of CRC.
细胞外囊泡 (EV) 中的 microRNAs 作为所有癌症类型的潜在诊断生物标志物引起了广泛关注。本研究旨在鉴定源自同基因结直肠癌细胞系 SW480 和 SW620 的脱落微泡 (sMVs) 和外泌体 (Exos) 的 microRNA 谱,并评估其预测结直肠癌 (CRC) 的能力。对亲本细胞裂解物 (CLs) 和高度纯化的 sMVs 和 Exos 中的 microRNAs 进行深度测序。我们重点研究了在 EV 中富集的 microRNAs 以及相对于原发性癌细胞 (SW480) 中失调的 microRNAs。我们使用来自 TCGA 的 594 个肿瘤 (代表不同的病理阶段) 和 11 个正常样本研究了 EV microRNA 特征预测 CRC 肿瘤的能力。在 SW480 和 SW620 细胞中,我们鉴定出 345 个 microRNAs,其中 61 个和 73 个在 SW620-CLs 中相对于 SW480-CLs 上调和下调。细胞 microRNAs 选择性分配到 EV 中导致每个细胞系中 sMVs 和 Exos 的 microRNA 特征不同。EV microRNA 谱的跨细胞系比较揭示了一组在原发性癌到转移过程中对 CRC 进展至关重要的 microRNAs。许多在 CLs 中不可检测的 microRNAs(<5 TPM)在分泌的 EV 中显著富集(>1000 TPM)。值得注意的是,在 SW480-CL 中不可检测但在 SW620-CL 中上调的 miR-7641 在两种细胞系分泌的 EV 中高度富集。Pearson 相关分析表明,EV microRNA 谱可用于预测 CRC 肿瘤,准确率约为 96%。我们的研究结果表明,CRC 细胞系的 EV microRNA 谱可能允许预测 CRC 肿瘤,并且 miR-7641 可能作为 CRC 特异性、非侵入性诊断和预后的有吸引力的候选物。